22 April 2015 РCRISPR Therapeutics Congratulates Scientific Founder Dr. Emmanuelle Charpentier on Addition to TIME Magazine’s 100 Most Influential People and Award of Louis Jeantet Prize for Medicine
learn more / See All News

CRISPR Therapeutics is a biopharmaceutical company created to translate CRISPR-Cas9, a breakthrough genome-editing technology, into transformative medicines with the potential to cure serious human diseases. learn more